-
A Message from Melany Duval
One of the things that makes Dana-Farber such a special place is our emphasis on teamwork.
-
The Dana-Farber Campaign
The success of our mission hinges on unrestricted gifts, including those raised through the Defy Cancer Fund.
-
Jonathan and Hope Ashner
A generous $100,000 gift from Jonathan and Hope Ashner was made to support the research of Elizabeth Buchbinder, MD. The gift will help to fuel Buchbinder’s groundbreaking investigations into melanoma and maximize progress against the disease.
-
Doron Broman
Doron Broman, a Miami-based real estate developer and stage IV pancreatic cancer patient, has given $150,000 to support research in pancreatic cancer under the direction of Kimmie Ng, MD, MPH. Broman came to Dana-Farber in 2015 with only months to live, but under the treatment of Ng, has defied the odds and is celebrating seven…
-
Jeffrey and Jennifer Goldstein
Jeffrey and Jennifer Goldstein made a generous gift in support of Pasi Jänne, MD, PhD, director of the Carole M. and Philip L. Lowe Center for Thoracic Oncology at Dana-Farber. The gift will support Jänne and his team’s continued research into targeted therapies in lung cancer, novel EGFR inhibitors, and mechanisms of drug resistance, ultimately…
-
Matthew Miller
Matthew Miller gave $100,000 to advance groundbreaking investigations in melanoma led by Rizwan Haq, MD, PhD. Miller’s support will help Haq uncover the genomic intricacies of drug resistance and explore new ways to enhance personalized medicine for patients.
-
National Foundation for Cancer Research
Dana-Farber recently received a $110,000 grant from the National Foundation for Cancer Research to study new, non-invasive approaches to identify specific subtypes of kidney cancer and particular genetic alterations in prostate cancer, with the aim of creating earlier detection and treatment interventions for patients with these diseases.
-
Terri Brodeur Breast Cancer Foundation
The Terri Brodeur Breast Cancer Foundation recently made grants totaling $200,000 to Dana-Farber Cancer Institute to fund two studies. One explores circulating tumor DNA at critical timepoints in early stage hormone receptor-positive breast cancer, and the second assesses how chemotherapy effects the tumor-immune microenvironment and estrogen receptor activity in young women with hormone receptor-positive breast…
-
Pan-Mass Challenge raises record $72 million to bring cures closer by the mile
On long journeys, landmarks and milestones show us where we are and how far we’ve come. Since 1980, the Pan-Mass Challenge (PMC), the beloved bike-a-thon and the nation’s most successful athletic fundraiser, has seen plenty of both.
-
Radical collaborations target intractable cancers
BTC has awarded $22.9 million in grants to Dana-Farber researchers working across multiple institutions to unlock the secrets of four difficult-to-treat cancers and intercept or develop cutting-edge treatments for them.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.